The Ledger, every show
Every statement that passed quotation and attribution checks, across all 44 shows. Pick shows below, then mix any filter with any other.
shows 




every show 44 of 44
Lacy: Screening Market for MRIs Is 1,000x Larger Than Diagnostic Market
“There was this potential screening use case for MRI machines that was a thousand times bigger than the diagnostic use case.”
Prenuvo CEO: Vast Majority of Detected Cancers Are Stage One
“And that's why the vast majority of the cancer that we catch is actually stage one or localized to the organ of origin.”
Lacy: No public critics of Prenuvo have experienced its scan firsthand
“And there's no one that's really spoken out against these technologies that actually has experienced it firsthand. In fact, most of those people bring their family members in and then start referring their patients.”
Lacy: Prenuvo scans detect chronic disease 10 to 20 years before symptoms
“I think one of the really fascinating things that we have discovered as we started to image more and more patients is we can see oftentimes at very early stages of chronic disease, 1020 years before you might ever feel symptoms.”
Lacy: Prenuvo Detects Cancer or Aneurysms in 1 in 20 Patients
“We just had cancer aneurysms in maybe one in 20 to one in 25 people, depending on the location.”
Lacy: Scanning every American biennially for cancer would cost ~$60B
“In fact, to just screen for cancer in the U.S. Using the techniques that we use, probably to scan every person in the U.S. Every two years would cost something like sixty billion dollars.”
Lacy: Radiology is constrained by legacy single-body-part imaging assumption
“The single biggest assumption underpinning all radiology today is that you only ever look at one part of the body at a time. And this is a throwback from a 150 years ago when we just had x-ray, an x-ray plate that they put behind your body to take a picture of…”
Lacy: Whole-body MRI screening will inevitably achieve widespread medical adoption
“And I think these statements that were made actually have also been made about pap smear between when it was invented and when it was adopted, mammograms. So this is a very, very natural Point in the journey from a potentially breakthrough screening technology…”
Lacy: Individual healthcare decisions fundamentally differ from population statistics
“It's also an argument that makes sense when you start to consider these interventions at a population level, because at a population level, we're all a statistic. But at the individual level, we only have one life. You know, if we lose that one, we don't get a…”
Lacy: Prenuvo Uses One Multi-Organ Radiologist Per Scan
“So we have one radiologist that looks at the entire body. They're trained in identifying what they see in, in every single organ. And then we have subspecialties that can chime in if there's something abnormal and they need help.”
Lacy: All Solid Tumors Are Harder Than Surrounding Tissue
“All solid tumors are harder than the surrounding tissue.”
Lacy: Longevity is closely linked to preserving mobility
“Longevity is so closely linked to mobility. Once you lose your mobility, you don't live much longer.”
Lacy: Cancer survivors and at-risk patients are Prenuvo's largest customer group
“The single biggest category are people that might've had cancer and worried that it's Coming back, or they have a strong family history of cancer, aneurysm, or disease, and for them, not being screened is obviously affecting their quality of life.”
Lacy: Patients with undiagnosed symptoms form Prenuvo's second-largest demographic
“The second biggest category are people that have actual symptoms, but they're indeterminate. They might have headaches or abdominal pain, particularly women that might have abdominal or pelvic pain, and they don't know what's causing it, and the health system …”
Lacy: Prenuvo aims to offer sub-$500 half-hour full-body scans
“Our goal as a company is one day that these are sub 500 dollar scan. It takes probably about half an hour or less, and they're available most everywhere.”
Lacy: US spends $130B annually on late-stage cancer drugs
“We spend a hundred and thirty billion dollars on late stage cancer drugs every year, let alone the obviously huge impact of people Passing away from this horrible disease.”